[...] ekstraktu z kory sosny wymagają dalszego rozwoju, aby potwierdzić jego skuteczne działanie również na człowieku. Literatura: Je-Won Ko, So-Won Park, Na-Rae Shin, et al. "Inhibitory effects of Pycnogenol®, a pine bark extract, in a rat model of testosterone propionate-induced benign prostatic hyperplasia,"Lab Anim Res. 2018 Sep;34(3):111-117.
[...] Immediate Release: Oct. 6, 2011 Media Inquiries: Jeff Ventura, 301-796-2807, [email protected] Consumer Inquiries: 888-INFO-FDA FDA approves Cialis to treat benign prostatic hyperplasia The U.S. Food and Drug Administration today approved Cialis (tadalafil) to treat the signs and symptoms of benign prostatic hyperplasia (BPH), a [...]
[...] (zdwojonej) efektywności - czyli jest to podówjny inhibitor 5ar typu I jak i II. "Dutasteride In spite of the promise of 5alpha-reductase inhibitors for benign prostatic hyperplasia (BPH), only one compound to date has reached the market: Merck & Co.'s finasteride (Proscar). However, as a selective type 1 isozyme inhibitor, [...]
[...] of the estrogen-androgen ratio in the human prostate. Their article in the Journal of Clinical Endocrinology and Metabolism concludes: "Our results indicate that the prostatic accumulation of DHT, estradiol, and estrone is in part intimately correlated with aging, leading with increasing age to a dramatic increase of the estrogen/androgen [...]
[...] may be enhanced with concomitant fat restriction. We undertook a pilot study to explore whether a flaxseed-supplemented, fat-restricted diet could affect the biomarkers of prostatic neoplasia. METHODS: Twenty-five patients with prostate cancer who were awaiting prostatectomy were instructed on a low-fat (20% of kilocalories or less), [...]